Join the Webinar and Get CME points

ONLY LIMITED SPOTS

By submitting this form you subscribe to our mailing list and agree to the privacy policy.

Genetic Disease Prevention with Clinically Actionable Incidental Findings

June 08, 2022 - 2PM CET (KSA: 3PM – UAE: 4PM)

Incidental findings are clinically actionable findings that are not related to present symptoms. Knowing them in advance is of great benefit as a disease development can be stopped. 

For example, Familial hypercholesterolemia is a genetic disorder of lipoprotein metabolism characterized by elevated serum cholesterol levels. Initially, this disease has no symptoms, however, if untreated, atherosclerosis may take place manifesting as chest pain, heart attacks, or even sudden death. Pathogenic variants (mutations) in 3 genes lead to this genetic disease. If a person undergoes a genetic test for breast cancer, has no symptoms related to high cholesterol levels, and gets a medical report with Familial hypercholesterolemia, Familial hypercholesterolemia is the incidental finding for this person.

Familial hypercholesterolemia has treatment options aimed to inhibit cholesterol synthesis in the body. Such a treatment delays or even stops cholesterol accumulation and thus prevents atherosclerosis.

During this Webinar, Sr. Director of Clinical Programs, Dr. Volha Skrahina, a biological scientist with long-standing experience in global clinical programs, will help you understand the following:
 

Volha is a strong leader, dedicated to all local and international partners. She started her career during her Bachelor’s thesis at the Republican Theoretical and Practical Centre – ‘Mother and Child’ in Minsk, Belarus. Afterwards, she investigated the translational regulation of the innate immune response in tuberculosis infection during her Master’s thesis at the Max Planck Institute in Berlin, Germany. 

She has completed her PhD thesis on the host fungal micronutrient interaction at the Hans Knoell Institute in Jena, Germany in 2018. From 2018 to 2020, Volha has worked as a Director of Clinical Studies at CENTOGENE. She executed multiple international clinical studies to analyse the prevalence of rare diseases allowing patients to be diagnosed at the earliest possible moment. Currently, Volha works as a Sr. Clinical Programs Director in Arcensus/Germany and US.

Speaker

Dr. Volha Skrahina,
Sr. Director Clinical Programs Arcensus GmbH

Volha is a strong leader, dedicated to all local and international partners. She started her career during her Bachelor’s thesis at the Republican Theoretical and Practical Centre – ‘Mother and Child’ in Minsk, Belarus. Afterwards, she investigated the translational regulation of the innate immune response in tuberculosis infection during her Master’s thesis at the Max Planck Institute in Berlin, Germany. 

She has completed her PhD thesis on the host fungal micronutrient interaction at the Hans Knoell Institute in Jena, Germany in 2018. From 2018 to 2020, Volha has worked as a Director of Clinical Studies at CENTOGENE. She executed multiple international clinical studies to analyse the prevalence of rare diseases allowing patients to be diagnosed at the earliest possible moment. Currently, Volha works as a Sr. Clinical Programs Director in Arcensus/Germany and US.

Speaker

Dr. Volha Skrahina,
Sr. Director Clinical Programs Arcensus GmbH

Genetic Diagnosis is the first step for a better future

May 11, 2022 - 2PM CET 

2022. All rights reserved by Arcensus GmbH

2022. All rights reserved by Arcensus GmbH

Incidental findings are clinically actionable findings that are not related to present symptoms. Knowing them in advance is of great benefit as a disease development can be stopped.

For example, Familial hypercholesterolemia is a genetic disorder of lipoprotein metabolism characterized by elevated serum cholesterol levels. Initially, this disease has no symptoms, however, if untreated, atherosclerosis may take place manifesting as chest pain, heart attacks, or even sudden death. Pathogenic variants (mutations) in 3 genes lead to this genetic disease. If a person undergoes a genetic test for breast cancer, has no symptoms related to high cholesterol levels, and gets a medical report with Familial hypercholesterolemia, Familial hypercholesterolemia is the incidental finding for this person.

Familial hypercholesterolemia has treatment options aimed to inhibit cholesterol synthesis in the body. Such a treatment delays or even stops cholesterol accumulation and thus prevents atherosclerosis.

During this Webinar, Sr. Director of Clinical Programs, Dr. Volha Skrahina, a biological scientist with long-standing experience in global clinical programs, will help you understand the following:


Duration: 45 minutes

(KSA: 4PM – UAE: 5PM) - Duration: 45 minutes

  • What are incidental findings?
  • Why it is important to know incidental findings?
  • How incidental findings can improve our health?
  • Which diseases belong to secondary findings?
  • How to proceed when incidental findings are detected?
  • How to stop disease development with simple measurements with real-life examples? 

REGISTER FOR FREE